BerandaSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
Tutup sebelumnya
$0,59
Rentang hari
$0,57 - $0,61
Rentang tahun
$0,55 - $6,18
Kapitalisasi pasar
2,05Â jt USD
Volume Rata-Rata
63,32Â rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 269,00Â rb | 30,58% |
Biaya operasional | 1,20Â jt | -42,82% |
Penghasilan bersih | -2,09Â jt | 6,43% |
Margin laba bersih | -775,65 | 28,35% |
Penghasilan per saham | — | — |
EBITDA | -1,53Â jt | 13,21% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,66Â jt | -15,43% |
Total aset | 11,63Â jt | -13,55% |
Total liabilitas | 3,52Â jt | 1,50% |
Total ekuitas | 8,10 jt | — |
Saham yang beredar | 3,47 jt | — |
Harga terhadap nilai buku | 0,83 | — |
Tingkat pengembalian aset | -40,63% | — |
Tingkat pengembalian modal | -45,55% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -2,09Â jt | 6,43% |
Kas dari operasi | -1,73Â jt | -60,59% |
Kas dari investasi | -6,00 rb | — |
Kas dari pembiayaan | 2,09Â jt | 4,72% |
Perubahan kas bersih | 340,00Â rb | -63,28% |
Arus kas bebas | -963,44Â rb | -333,01% |
Tentang
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Didirikan
1 Jan 2003
Situs
Karyawan
45
